The Use of Sunscreen Starting on the First Day After Ablative Fractional Skin Resurfacing

PIH Clinical Trial

Official title:

The Use of Sunscreen Starting on the First Day After Ablative Fractional Skin Resurfacing - A Pilot Study.

Clinical Trial Details — Status: Unknown status

Administrative data

• NCT number: NCT01756664
• Other study ID #: Siriraj-Eucerin01
• Secondary ID: SI402/2012
• Status: Unknown status
• Phase: N/A
• First received: December 20, 2012
• Last updated: December 26, 2012
• Start date: August 2012
• Est. completion date: August 2013

Study information

• Verified date: August 2012
• Source: Mahidol University
• Contact: Rungsima Wanitphakdeedecha, MD
• Email: rungsima.wan[@]mahidol.ac.th
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

- The use of sunscreen on the first day after fractional ablative skin resurfacing may reduce the risk of post-inflammatory hyperpigmentation

Description:

• The use of sunscreen on the first day after fractional ablative skin resurfacing may reduce the risk of post-inflammatory hyperpigmentation (PIH)

• Therefore, we conducted the study to evaluate the efficacy of the use of sunscreen on the first day after fractional ablative skin resurfacing in reducing the risk of PIH.

Recruitment information / eligibility

• Status: Unknown status
• Enrollment: 20
• Est. completion date: August 2013
• Est. primary completion date: December 2012
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients who want to receive fractional ablative laser resurfacing for acne scars

Exclusion Criteria:

• Pregnancy

• Lactation

• Age < 18

Related Conditions & MeSH terms

• PIH

Intervention

Other:
• Sunscreen

• Vaseline

Locations

Country	Name	City	State
Thailand	Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University	Bangkok

Sponsors (1)

Lead Sponsor	Collaborator
Mahidol University

Country where clinical trial is conducted

Thailand, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Transepidermal Water Loss		1 Week
Primary	Melanin Index		3 Month
Secondary	Erythema Index		3 Months